CD4 and breast cancer: In systemically untreated breast cancer patients, CD4+ T cells were found to be the principal component of the tumor infiltrating lymphocytes (TIL) and along with TH1, TH2 and TH17 subtypes, were also enriched for Tfh populations (46).